ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 1844

$709K Total Retail Price of All Prescriptions

Rank: 146 out of 1844

501 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 9,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 488 310 S3 1 2
LEVOTHYROXINE SODIUM 358 282 2 1
OMEPRAZOLE 341 245 3 5
CARVEDILOL 331 269 4 22
AMLODIPINE BESYLATE 320 240 5 6
FUROSEMIDE 320 244 5 7
METFORMIN HCL 308 241 7 8
CITALOPRAM HBR 297 226 8 19
LISINOPRIL 289 264 9 4
PRAVASTATIN SODIUM 268 203 10 10
TRAMADOL HCL 226 177 11 18
HYDROCHLOROTHIAZIDE 202 151 12 9
SIMVASTATIN 189 145 13 3
ATENOLOL 188 156 14 17
GABAPENTIN 161 56 15 15
CEPHALEXIN 156 124 16 56
SERTRALINE HCL 152 97 17 21
ATORVASTATIN CALCIUM 142 104 18 12
ZOLPIDEM TARTRATE 140 92 19 23
MELOXICAM 133 89 20 28
NEXIUM 130 90 21 31
ALLOPURINOL 117 72 22 29
PANTOPRAZOLE SODIUM 116 99 23 32
RISPERIDONE 115 98 24 65
POTASSIUM CHLORIDE 110 87 25 16
RANITIDINE HCL 105 72 26 38
GLIMEPIRIDE 102 76 27 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 70 27 20
AZITHROMYCIN 99 64 29 37
METOPROLOL SUCCINATE 96 80 30 14
SPIRONOLACTONE 95 72 31 60
SPIRIVA 94 66 32 57
AMITRIPTYLINE HCL 94 0 R 32 72
FLUTICASONE PROPIONATE 90 54 34 50
NABUMETONE 84 65 35 158
WARFARIN SODIUM 83 66 36 13
ADVAIR DISKUS 81 36 37 51
OXYCODONE-ACETAMINOPHEN 76 42 S2 38 94
PROAIR HFA 75 32 39 45
CLOPIDOGREL 74 51 40 34
LEVOFLOXACIN 74 41 40 78
PREDNISONE 73 54 42 40
METOPROLOL TARTRATE 73 68 42 11
TRAZODONE HCL 73 59 42 43
DONEPEZIL HCL 72 63 45 26
COUMADIN 71 71 46 175
POLYETHYLENE GLYCOL 3350 71 67 46 39
LOSARTAN POTASSIUM 70 50 48 24
CYCLOBENZAPRINE HCL 68 35 R 49 53
VESICARE 68 46 49 182
FLUOXETINE HCL 67 42 51 41
KLOR-CON M10 66 50 52 149
FAMOTIDINE 64 45 53 63
NAMENDA 63 56 54 33
TAMSULOSIN HCL 62 60 55 27
LANTUS 61 36 56 42
BENAZEPRIL HCL 60 49 57 75
ROPINIROLE HCL 57 27 58 76
VENLAFAXINE HCL ER 55 24 59 93
MIRTAZAPINE 54 54 60 49
TORSEMIDE 54 33 60 118
RAMIPRIL 53 39 62 116
PLAVIX 52 33 63 61
DIGOXIN 52 52 63 67
ESCITALOPRAM OXALATE 51 38 65 52
GEMFIBROZIL 50 46 66 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.